Product Information
EPOGEN 10,000 UNIT/ML VIAL is a brand product labeled by Amgen Inc., priced at $161.8001 per ML under NDC 55513014410. Its NADAC has been published 164 times since Nov 19, 2014.
Strength
10000 [iU]/mL
Manufacturer
Amgen Inc.NDC
55513014410
Classification
Brand
Dosage Form
SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
EPOETINApproval Type
Biologic (BLA)
FDA Application
BLA103234On Market Since
8/16/1993
Pharmacological Classes
Price Statistics
The NADAC for EPOGEN 10,000 UNIT/ML VIAL has been published 164 times since Nov 19, 2014, and over the history we have for it it has risen 41.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $161.8001 per ML |
|---|---|
| All-time high | $161.8392 (Jun 10, 2026) |
| All-time low | $114.6682 (Nov 19, 2014) |
| 52-week high | $161.8392 |
| 52-week low | $161.5886 |
| Median price | $161.0358 |
| Average price | $152.1174 |
| Largest weekly change | +33.1% (Apr 17, 2024) |
| Weeks tracked | 164 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the epoetin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
epoetin alfa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Erythropoiesis-stimulating Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPOGEN 10,000 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for EPOGEN 10,000 UNIT/ML VIAL, manufactured by Amgen Inc., is $161.8001 per ML (NDC 55513014410), effective Sep 30, 2026.
How has the price of EPOGEN 10,000 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for EPOGEN 10,000 UNIT/ML VIAL has risen 41.1%. It has been tracked across 164 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for EPOGEN 10,000 UNIT/ML VIAL?
Since Nov 19, 2014, the NADAC for EPOGEN 10,000 UNIT/ML VIAL has ranged from a low of $114.6682 (Nov 19, 2014) to a high of $161.8392 (Jun 10, 2026), with a median of $161.0358 per ML.
Are there cheaper alternatives to EPOGEN 10,000 UNIT/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of EPOGEN 10,000 UNIT/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EPOGEN 10,000 UNIT/ML VIAL?
EPOGEN 10,000 UNIT/ML VIAL (NDC 55513014410) is labeled by Amgen Inc., and CMS classifies it as a brand product.